Most Popular White Papers
Health Care Industry
Industry: Email Alert RSS FeedForest Labs received FDA approval to market Benicar
Drug Store News, May 20, 2002 by Diane West, James Frederick
Forest Labs received FDA approval to market Benicar (olmesartan medoxomil), a new hypertension drug that is part of the growing angiostensin II receptor blocker, or ARB, class. Sankyo Pharma discovered and developed Benicar, and Forest will be a long-term co-promotion partner in the U.S. market. A June launch is expected.
COPYRIGHT 2002 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning